Company Long-Term Loans and Borrowings: Supernus Pharma (SUPN)
High barriers to entry and patent protection for neurological drugs create a legal monopoly for Supernus Pharmaceuticals (SUPN). The company's long-term debt statistics demonstrate liability dynamics, where the value of 0.03 records the metric level. Supernus Pharmaceuticals (SUPN) leads in the therapy of epilepsy and ADHD, expanding its market share. Management is currently adapting the asset portfolio, with expectations for new strategic acquisitions from the leadership team.
Summary analytical data breakdowns for Supernus Pharma (SUPN)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
Total Debt to Capital Supernus Pharmaceuticals|SUPN - Long-Term Debt to Equity|Current Liabilities to Equity Supernus Corp|SUPN - Company Aggregate Debts|Debts to Book Value Supernus|SUPN - Company Long-Term Debt|Company Short-Term Loans and Borrowings Supernus|Immediate Liquidity Ratio supernus.com
- earnings and market multiples details:
Summary company analytics:Supernus Pharmaceuticals
Conservative capital demands absolute transparency of the liability structure to confirm the issuer's financial stability. This indicator captures the aggregate of loans with a maturity of more than one year, where an increase in borrowing volume signals business scaling but elevates risks in a rising interest rate environment. For the innovative biopharmaceutical company Supernus Pharmaceuticals (SUPN), which develops complex CNS drugs, changes in the enterprise's long-term debt reflect the cost of investing in scientific potential.
Competitors of Supernus Pharmaceuticals (SUPN)
Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Debt Xenon Pharmaceuticals|vikingtherapeutics.com (VKTX) - Long-Term Debt Volume|Company Long-Term Liabilities CPRX (Catalyst Pharmaceuticals, Inc.)|Company Long-Term Debts Denali (DNLI)|Company Long-Term Debt Harmony Pharma HRMY|BHVN (Biohaven Corp) - Long-Term Liabilities|Amylyx Pharmaceuticals - Company Long-Term Debts|Long-Term Debt trevitherapeutics.com|Praxis Precision Medicines, Inc. (PRAX) - Company Long-Term Debt|Anavex - Company Long-Term Loans and Borrowings|Company Long-Term Debt CeriBell Corp|Company Long-Term Indebtedness PRTA (prothena.com)|Company Long-Term Liabilities ALEC (Alector, Inc.)|Company Long-Term Debts annexonbio.com (ANNX)|Company Long-Term Debt Omeros OMER|Long-Term Debt Volume Neurogene Inc (NGNE)|ACIU: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings VYGR (Voyager Corp)|Neumora Therapeutics (NMRA) - Company Long-Term Debt|Long-Term Liabilities SCLX (scilexholding.com)|TVGN (Tevogen Bio) - Company Long-Term Debts|ACOG: Company Long-Term Loans and Borrowings|Company Long-Term Debts CGTX|Company Long-Term Debts Inhibikase Pharma (IKT)|Company Long-Term Debt Cassava Sciences, Inc. SAVA|Company Long-Term Loans and Borrowings ASRT|COYA - Company Long-Term Debt|Vistagen Therapeutics (VTGN) - Company Long-Term Liabilities|OVID: Company Long-Term Debts|Acumen Pharmaceuticals, Inc (ABOS) - Company Long-Term Debts|CRVO (CervoMed Inc.) - Company Long-Term Debts|Company Long-Term Liabilities Alterity Therapeutics Ltd (ATHE)|Company Long-Term Debts CLNN|PEPG - Long-Term Debt|Jupiter Neurosciences Inc - Company Long-Term Liabilities|Company Long-Term Debts Relmada Corp RLMD|ANVS: Company Long-Term Liabilities|Grace Therapeutics, Inc. - Amount of Long-Term Liabilities|AIFF: Company Long-Term Debts|KLTO - Long-Term Debt Volume|NRSN (NeuroSense Therapeutics Ltd) - Company Long-Term Debts|Company Long-Term Liabilities Reviva Pharmaceuticals, Inc. (RVPH)|Company Long-Term Debts MTVA|Company Long-Term Debts neuraxis.com (NRXS)|Company Long-Term Debt Helius Medical Technologies HSDT|Passage Bio Inc. - Company Long-Term Debt|NEUP - Company Long-Term Debt|Long-Term Debt Volume Minerva NERV|Athira Pharma, Inc. (ATHA) - Company Long-Term Debt|ADXN - Long-Term Debt Volume|Company Long-Term Liabilities ALZN|Company Long-Term Debts Cyclerion|Company Long-Term Debt Protagenic Therapeutics (PTIX)|KTTA: Long-Term Liabilities|Company Long-Term Debt Cortigent CRGT|ATXI: Company Long-Term Indebtedness|BCLI - Company Long-Term Debt|CARA (Cara Therapeutics Inc.) - Company Long-Term Indebtedness|CHRO: Company Long-Term Debts|Long-Term Debt Eliem Therapeutics Inc. (ELYM)|Company Long-Term Liabilities ITCI|Company Long-Term Debts longboardpharma.com|Company Long-Term Debt Marinus Pharmaceuticals, Inc. (MRNS)|NKGN (NKGen Biotech Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debt NeuroBo NRBO|Sage Therapeutics Inc (SAGE) - Long-Term Debt|SNPX - Company Long-Term Debt|Long-Term Debt Volume trevena.com TRVN|VIGL (vigilneuro.com) - Company Long-Term Liabilities|Anew Medical Inc. (WENA) - Company Long-Term Debts|Company Long-Term Debt Cerevel